Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Not Confirmed
Not Confirmed
04-05 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Industry Trade Show
Not Confirmed
04-05 March, 2026
Digital content

20 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/20/3222341/0/en/Tempest-Announces-Record-Date-for-Anticipated-Dividend-Distribution-of-Warrants-to-Stockholders.html

06 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260106778477/en/Lineage-Takes-Delivery-of-Gene-edited-Hypoimmune-Cell-Line-Under-Partnership-With-Factor-Bioscience

19 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/19/3191025/0/en/Tempest-Announces-Strategic-Acquisition-of-New-Dual-CAR-T-Programs-from-Factor-with-Simultaneous-Runway-Extension-Projected-to-Mid-2027.html

26 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/factor-bioscience-files-complaint-against-cellectis-and-astrazeneca-alleging-infringement-of-foundational-gene-editing-patents-302568302.html

10 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/factor-bioscience-to-unveil-imacrophages-engineered-to-combat-solid-tumors-at-the-isscr-annual-meeting-302477389.html

17 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/17/2964799/0/en/Eterna-Therapeutics-and-Factor-Bioscience-Announce-Exclusive-License-and-Collaboration-Agreement-to-Accelerate-Cell-Therapy-Development-for-Oncology-Autoimmune-and-Rare-Diseases.html
ABOUT THIS PAGE